Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125844161 | 12584416 | 1 | I | 20131023 | 20160722 | 20160722 | PER | JP-SA-2013SA109630 | AVENTIS | LITERATURE CITATION: HARA T, MOMOZONO H, IMAI S, MIYAZAKI A, TERAKAWA T, FURUKAWA J ET AL. RESULT OF BCG MAINTENANCE THERAPY FOR UROTHELIAL BLADDER CARCINOMA RECURRENT PROPHYLAXIS IN OUR DEPARTMENT. THE 25TH ANNUAL MEETING OF THE PREVENTIVE NEPHROLOGY AND UROLOGY 07 JULY 2016; 35 (8). | 0.00 | E | M | Y | 0.00000 | 20160722 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125844161 | 12584416 | 1 | PS | IMMUCYST | BACILLUS CALMETTE-GUERIN SUBSTRAIN CONNAUGHT LIVE ANTIGEN | 1 | Unknown | UNKNOWN | 103943 | 81 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125844161 | 12584416 | 1 | Immunisation |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125844161 | 12584416 | Dysuria | |
| 125844161 | 12584416 | Haematuria | |
| 125844161 | 12584416 | Pollakiuria | |
| 125844161 | 12584416 | Pyrexia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |